Meridian Bioscience (VIVO) Reports In-Line Q3 EPS, Miss on Revenues; Affirms Fiscal 2018 Guidance
Go back to Meridian Bioscience (VIVO) Reports In-Line Q3 EPS, Miss on Revenues; Affirms Fiscal 2018 Guidance| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 5.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.74 | 52 Week High | $21.49 | |||
| Open | $5.74 | 52 Week Low | $15.75 | |||
| Day High | $5.74 | P/E | 6.52 | |||
| Day Low | $5.74 | EPS | $0.88 | |||
| Volume | 16,406 | |||||
